Translational Regulation of SARS-CoV-2 in response to viral S protein-induced signaling

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

Document text

Principal Investigator: BARSANJIT  MAZUMDER
Organization: CLEVELAND STATE UNIVERSITY
Fiscal Year: 2024
Award: $185,625
Funding agency: National Institute of Allergy and Infectious Diseases

Adopted folding of the RNA elements within the genomes of RNA viruses allows binding of host and viral
proteins and plays an essential role in host-virus interactions. However, the mechanistic insights on how these
RNA elements could sense the transduced signals from host cells are lacking for SARS-CoV-2. This project is
based on our recent discovery of a novel and structurally conserved RNA element within the ORF1a RNA and
S mRNA of SARS-CoV-2. Our studies showed that this element regulates the translation of viral proteins in
response to viral S protein-induced signaling in human lung cells. In prior studies, we identified a translational
silencing-dependent mechanism of controlling inflammation in myeloid cells. These studies showed that the
assembly of an L13a-dependent multi-protein RNA-binding complex (IFN-gamma-activated-inhibitor
of translation) or GAIT complex on the GAIT elements found in the 3' untranslated region (UTR) of target
mRNAs causing translational inhibition. Our studies also showed the physiological importance of this
mechanism as an endogenous defense against inflammation. Importance of the GAIT-like elements in human
responses to coronavirus and other respiratory pathogens is emerging from the published studies by us and
others. Our preliminary work presented in this proposal shows that treatment of human lung cells with SARS-
CoV-2 S protein activates a DAP kinase-dependent signaling mechanism causing the release of L13a from
large ribosomal subunit followed by the formation of L13a-dependent RNA-binding complex on “GAIT-like” viral
RNA elements of SARS-CoV-2, thus inhibiting translation. This led us to name these
elements virus activated inhibitor of translation (VAIT) elements. Together, these studies lead us to
hypothesize that ribosome-released form of L13a upon SARS-CoV-2 infection promotes the assembly of RNA-
binding complex on VAIT element of ORF1a RNA and S mRNA, which is biochemically and functionally distinct
from IFN-g-induced GAIT complex. The role of translational inhibition caused by the VAIT complex is testable.
We will test this hypothesis by pursuing the following two aims. Aim 1. To elucidate the composition of the
translation inhibitory VAIT RNP complex and identification of the upstream kinase in signaling. In this aim we
will use the combined approach of Gel filtration, RNA-affinity chromatography and mass spectrometry to
identify the subunits of the RNA-binding complex. Small molecule inhibitors and siRNA of the potential kinases
will be used to dissect the signaling aspect. Aim 2. To test the virological significance of VAIT element
mediated translational silencing. In this aim we will use extensive mutation in the VAIT element of the S gene
within the viral genomic RNA of the trans-complementation system to test the role of VAIT element-mediated
translational silencing in the intracellular expression of viral proteins and nucleic acid. Mechanistic insights on
VAIT element mediated translational silencing of SARS-CoV-2 RNAs may provide novel targets of small
molecule intervention and facilitate the development of next-generation mRNA vaccines.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><3' Untranslated Regions><3'UTR><Adopted><Affinity Chromatography><Binding><Biochemical><Blood monocyte><COVID-19 S protein><COVID-19 genome><COVID-19 infection><COVID-19 spike><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 virus><COVID-19 virus genome><COVID-19 virus infection><COVID19 genome><COVID19 infection><COVID19 virus><COVID19 virus genome><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Chemokine Receptor Gene><Chemotactic Cytokines><CoV-2><CoV2><Complement><Complement Proteins><Complex><Coronaviridae><Coronavirus><DAP kinase><Development><Elements><Exclusion Chromatography><Foundations><Gastroenteritis><Gel Chromatography><Gel Filtration><Gel Filtration Chromatography><Gel Permeation Chromatography><Genes><Genetic Alteration><Genetic Change><Genetic defect><Genome><Homologous Chemotactic Cytokines><Human><IFN-Gamma><IFN-g><IFN-γ><IFNG><IFNγ><Immune Interferon><Infection><Inflammation><Inflammatory><Innate Immune Response><Intercrines><Interferon Gamma><Interferon Type II><Intervention><Intervention Strategies><Intracellular Communication and Signaling><Journals><Kinases><Laboratories><Lentivirinae><Lentivirus><Lung><Lung Respiratory System><Macrophage><Magazine><Marrow monocyte><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediating><Messenger RNA><Modeling><Modern Man><Molecular Interaction><Molecular Sieve Chromatography><Mutation><Myeloid Cells><Mφ><Names><Non-Polyadenylated RNA><Nucleic Acids><Phosphorylation><Phosphotransferase Gene><Phosphotransferases><Physiologic><Physiological><Play><Process><Protein Phosphorylation><Proteins><Publishing><RNA><RNA Binding><RNA Folding><RNA Gene Products><RNA Viruses><RNA bound><RNA vaccine><RNA-Binding Proteins><RNA-based vaccine><Recombinants><Replication Unit><Replicon><Respiratory syncytial virus><Ribonucleic Acid><Ribonucleoproteins><Ribosomal Proteins><Ribosomes><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 S><SARS-CoV-2 S protein><SARS-CoV-2 genome><SARS-CoV-2 infection><SARS-CoV-2 spike><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV2><SARS-CoV2 genome><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SIS cytokines><Series><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome related corona virus 2><Short interfering RNA><Signal Induction><Signal Transduction><Signal Transduction Systems><Signaling><Size Exclusion Chromatography><Small Interfering RNA><System><Testing><Translational Inhibition><Translational Regulation><Translational Repression><Translations><Transphosphorylases><Viral Diseases><Viral Gene Products><Viral Gene Proteins><Viral Proteins><Virulence><Virus><Virus Diseases><Virus-like particle><Work><Wuhan coronavirus><affinity purification><biological signal transduction><chemoattractant cytokine><chemokine><chemokine receptor><complement system><complementation><corona virus><coronavirus disease 2019 S protein><coronavirus disease 2019 genome><coronavirus disease 2019 infection><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 virus><coronavirus disease 2019 virus genome><coronavirus disease-19 virus><death-associated protein kinase><developmental><genetic information><genome mutation><genomic RNA><hCoV19><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><inhibitor><insight><interventional strategy><kinase inhibitor><lFN-Gamma><mRNA><mRNA vaccine><mRNA-based vaccine><member><monocyte><nCoV2><name><named><naming><next generation><novel><pulmonary><respiratory pathogen><response><severe acute respiratory syndrome coronavirus 2 genome><siRNA><small molecular inhibitor><small molecule><small molecule inhibitor><social role><spike proteins on SARS-CoV-2><translation><upstream kinase><viral RNA><viral fitness><viral genomics><viral infection><virology><virus RNA><virus genomics><virus host interaction><virus infection><virus protein><virus-induced disease><virus-like nanoparticles><viruslike particle>